Covered recipient · General Payments record
MATTHEW DOEPKING
General Payments · PY2022–2024
$2,055.46
- Reported across 77 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $652.11 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $314.23 | 15 |
| GENZYME CORPORATION | $125.39 | 1 |
| Galderma Laboratories, L.P. | $79.78 | 4 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $53.62 | 2 |
| Incyte Corporation | $53.40 | 2 |
| REVANCE THERAPEUTICS, INC. | $25.69 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.97 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113840580 | CMS |
| ABBVIE INC. | $27.30 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113840585 | CMS |
| ABBVIE INC. | $22.29 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113840591 | CMS |
| ABBVIE INC. | $16.25 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113840597 | CMS |
| ABBVIE INC. | $23.47 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113840604 | CMS |
| ABBVIE INC. | $14.37 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113840610 | CMS |
| ABBVIE INC. | $21.64 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113840616 | CMS |
| ABBVIE INC. | $21.33 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113840621 | CMS |
| ABBVIE INC. | $26.54 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113840631 | CMS |
| ABBVIE INC. | $13.49 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113840637 | CMS |
| ABBVIE INC. | $32.23 | 09/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113840643 | CMS |
| ABBVIE INC. | $21.28 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113840568 | CMS |
| ABBVIE INC. | $20.55 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113840563 | CMS |
| ABBVIE INC. | $15.53 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113840557 | CMS |
| ABBVIE INC. | $15.99 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113840575 | CMS |
| Galderma Laboratories, L.P. | $22.36 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145354355 | CMS |
| Galderma Laboratories, L.P. | $19.82 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145354357 | CMS |
| Galderma Laboratories, L.P. | $16.80 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145354359 | CMS |
| Galderma Laboratories, L.P. | $20.80 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145354361 | CMS |
| GENZYME CORPORATION | $125.39 | 10/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139719606 | CMS |
| Incyte Corporation | $27.55 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141200021 | CMS |
| Incyte Corporation | $25.85 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141316881 | CMS |
| REVANCE THERAPEUTICS, INC. | $25.69 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147938341 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $26.66 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152254509 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $26.96 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152254513 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.